Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nearly 40 Early- to Late-Stage Med Device Companies Confirmed to Date to Present at Medtech Insight and Windhover Informationís ''Investment In Innova

Abstract:
February 27-29, 2008, The Venetian, Las Vegas

Nearly 40 Early- to Late-Stage Med Device Companies Confirmed to Date to Present at Medtech Insight and Windhover Informationís ''Investment In Innova

NEWPORT BEACH, CA | Posted on December 20th, 2007

Medtech Insight, a division of Windhover Information, Inc. and a leading provider of business information for the medical device industry, has announced that almost 40 promising early- to late-stage medical device companies seeking funding and/or strategic partnership are now confirmed to present at its "Investment In Innovation (In3) West" conference, being held February 27-29, 2008 at The Venetian Resort-Hotel-Casino in Las Vegas, Nevada. The two-day In3 West event (www.windhover.com/in3west08) - the company's 29th In3 conference - will showcase a total of over 50 innovative young medtech companies from around the world presenting (many for the first time on our stage) to an audience of 250+ senior business development and investment executives from the leading medical technology and healthcare investment firms, for purposes of raising funding or forming strategic partnerships.

Presentations from this group of cutting-edge early- to late-stage companies, carefully selected by our staff and Advisory Board of expert healthcare investment professionals, will encompass a wide variety of high-growth device sectors, including cardiovascular therapeutics and diagnostics/interventional cardiology, diagnostics, drug delivery, imaging, minimally invasive surgery, nanotechnology, neurostimulation, oncology, orthopedics/spine, peripheral vascular, stem cells, stroke management, tissue engineering, and wound management, to mention only a few. Presenters confirmed to date include Angel Medical Systems, Armune BioScience, BioTelligent, Cardiac Output Technologies, Cohera Medical, CoreSpine Technologies, Crospon, Deca-Medics, eCardio Diagnostics, HealthLink Europe, HemoBioTech, Hepgen, Infrared Sciences, Innovent Medical Solutions, Light Sciences Oncology, Minnow Medical, Moerae Matrix, Nerites, Nesos Health, Photo Dynamic Therapy, PolyRemedy, Portland Orthopaedic, Praxim, Provista Life Sciences, Seno Medical Instruments, Sunshine Heart Company, TheraCardia, ThermopeutiX, Tissue Genetics, Ultimate Spine, ValveXchange, VeinAid, Victhom Human Bionics, Vivoxid, Xylos Corporation, and Zassi Medical Evolutions, among many others being added to the program regularly.

The In3 West format will include focused 10-minute presentations by a senior executive from each presenting company to our full audience, each followed immediately by one-on-one meetings with interested parties in private breakout rooms. The event will also feature a presenting company product exhibition/networking reception, plenary sessions by device industry thought leaders, a Manufacturer Perspective panel discussion/case study titled "What Are Buyers Looking for in 2008?", a Venture Perspective panel discussion/case study, "Doing Innovative or Unconventional Deals," educational workshops for start-up companies, and much more.

Event co-sponsors include AdvaMed, Battelle, Business Wire, Curran International, MDMA, Medmarc and The Hartford, Medical Capital Advisors, The MedTech Group, and Ronald Trahan Associates.

Medtech Insight and its parent company, Windhover Information, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1300 emerging medical technology company presenters and over 7000 attendees have participated at In3 events over the past 7 years.

To register to attend, or if your company is interested in presenting, call Kristy Grimes of Medtech Insight at 480-985-9512, 888-202-5939 toll-free in the U.S., or e-mail . Attendees can register on the Medtech Insight website at www.windhover.com/in3west08; the discounted $1295 attendee registration rate ($200 off) expires December 31, 2007.

Visit http://www.medtechinsight.com/pastpresenters.html for a full list of previous Medtech Insight conference presenters and their technology descriptions. To read what past attendees and industry experts think of Medtech Insight's investment and partnering events, please visit http://www.medtechinsight.com/in3success.html .

The company's Spring 2008 In3 event -- In3 Europe -- will be held in Paris, France, April 28-30. Information on this exciting international medtech investment conference will be posted soon on the Medtech Insight website.

####

About Medtech Insight
Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace.

For more information, please click here

Contacts:
Medtech Insight, a division of Windhover Information Inc.
Kristy Grimes, 480-985-9512
or 888-202-5939 toll-free in the U.S.

www.medtechinsight.com
www.windhover.com

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014

Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014

Harris & Harris Group Letter to Shareholders on Website August 19th, 2014

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014

Nanomedicine

Recruiting bacteria to be technology innovation partners: September 17th, 2014

Nanoscience makes your wine better September 17th, 2014

Treatment of Cell Infection by Nanotechnology September 15th, 2014

Iranian Nanotechnology Scientists Produce Polymeric Scaffolds for Tissue Engineering September 11th, 2014

Announcements

Nanoscience makes your wine better September 17th, 2014

Carbon Sciences Developing Breakthrough Technology to Mass-Produce Graphene -- the New Miracle Material: Company Enters Into an Agreement With the University of California, Santa Barbara (UCSB) to Fund the Further Development of a New Graphene Process September 16th, 2014

Nanoribbon film keeps glass ice-free: Rice University lab refines deicing film that allows radio frequencies to pass September 16th, 2014

Effective Nanotechnology Innovations to Receive Mustafa Prize September 16th, 2014

Events/Classes

Dolomite to launch Meros TCU-100 temperature controller at Lab-on-a-Chip & Microarray World Congress September 15th, 2014

Seeking Nanoscale Defenses for Biological and Chemical Threats: WPI co-organizes a NATO workshop to improve the detection and decontamination of biological and chemical agents September 13th, 2014

PETA science consortium experts to present at international nanotechology workshop: PETA International Science Consortium, Ltd., Is a Sponsor of Nano Risk Analysis II September 12th, 2014

DELMIC and Phenom-World announce Delphi, the worldís first fully integrated tabletop fluorescence and electron microscope September 8th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE